ES523039A0 - "un procedimiento para la preparacion de derivados del indol" - Google Patents
"un procedimiento para la preparacion de derivados del indol"Info
- Publication number
- ES523039A0 ES523039A0 ES523039A ES523039A ES523039A0 ES 523039 A0 ES523039 A0 ES 523039A0 ES 523039 A ES523039 A ES 523039A ES 523039 A ES523039 A ES 523039A ES 523039 A0 ES523039 A0 ES 523039A0
- Authority
- ES
- Spain
- Prior art keywords
- indol
- derivatives
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8216526 | 1982-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES523039A0 true ES523039A0 (es) | 1984-10-01 |
ES8407473A1 ES8407473A1 (es) | 1984-10-01 |
Family
ID=10530876
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES523039A Expired ES8407473A1 (es) | 1982-06-07 | 1983-06-07 | "un procedimiento para la preparacion de derivados del indol" |
ES529802A Granted ES529802A0 (es) | 1982-06-07 | 1984-02-16 | Un procedimiento para la preparacion de derivados del indol |
ES544281A Expired ES8609247A1 (es) | 1982-06-07 | 1985-06-17 | Un procedimiento para la preparacion de derivados del indol |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES529802A Granted ES529802A0 (es) | 1982-06-07 | 1984-02-16 | Un procedimiento para la preparacion de derivados del indol |
ES544281A Expired ES8609247A1 (es) | 1982-06-07 | 1985-06-17 | Un procedimiento para la preparacion de derivados del indol |
Country Status (33)
Country | Link |
---|---|
US (1) | US4816470A (es) |
JP (1) | JPS5942366A (es) |
KR (1) | KR900006681B1 (es) |
AT (1) | AT381933B (es) |
AU (1) | AU566149B2 (es) |
BE (1) | BE896986A (es) |
CA (1) | CA1199643A (es) |
CH (1) | CH657359A5 (es) |
CY (1) | CY1458A (es) |
CZ (1) | CZ280529B6 (es) |
DE (2) | DE3320521A1 (es) |
DK (1) | DK260183D0 (es) |
DO (1) | DOP1989476000A (es) |
ES (3) | ES8407473A1 (es) |
FI (1) | FI79530C (es) |
FR (1) | FR2530625B1 (es) |
GB (1) | GB2124210B (es) |
GR (1) | GR79215B (es) |
HK (1) | HK14789A (es) |
IE (1) | IE55358B1 (es) |
IL (1) | IL68913A (es) |
IT (1) | IT1170387B (es) |
KE (1) | KE3833A (es) |
LU (1) | LU84852A1 (es) |
MX (1) | MX9202623A (es) |
MY (1) | MY8700179A (es) |
NL (1) | NL193694C (es) |
NZ (1) | NZ204482A (es) |
PH (1) | PH19908A (es) |
PT (1) | PT76830B (es) |
SE (1) | SE452459B (es) |
SK (1) | SK277877B6 (es) |
ZA (1) | ZA834110B (es) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
HU196752B (en) * | 1983-12-06 | 1989-01-30 | Glaxo Group Ltd | Process for production of medical compositions containing indole-derivatives and these compounds |
GB8332434D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Production of chemical compounds |
GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
US5270333A (en) * | 1986-01-28 | 1993-12-14 | Glaxo Group Limited | Indole derivatives |
GB8601959D0 (en) * | 1986-01-28 | 1986-03-05 | Glaxo Group Ltd | Indole derivatives |
GB8615599D0 (en) * | 1986-06-26 | 1986-07-30 | Glaxo Group Ltd | Chemical compounds |
GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
PT88255B (pt) * | 1987-08-13 | 1995-03-01 | Glaxo Group Ltd | Processo para a preparacao de derivados do indole |
US5225431A (en) * | 1987-10-23 | 1993-07-06 | Burroughs Wellcome Co. | Therapeutic substituted indole compounds and compositions thereof |
GB8903036D0 (en) * | 1989-02-10 | 1989-03-30 | Glaxo Group Ltd | Chemical compounds |
HUT57185A (en) * | 1990-03-21 | 1991-11-28 | Merrell Dow Pharma | Process for producing 8-sulfamil-methylen-2-amino-tetraline derivatives and pharmaceutical compositions containing them |
US5155218A (en) * | 1990-05-08 | 1992-10-13 | Neurogenetic Corporation | Dna encoding human 5-ht1d receptors |
US5935925A (en) * | 1990-05-08 | 1999-08-10 | Synaptic Pharmaceutical Corporation | Methods of treating migraine and compounds useful for such methods |
MC2210A1 (fr) * | 1990-06-07 | 1992-11-26 | Wellcome Found | Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer |
GB9013845D0 (en) * | 1990-06-21 | 1990-08-15 | Glaxo Group Ltd | Process |
CA2043709C (en) * | 1990-06-29 | 2002-01-22 | David W. Smith | Antimigraine alkoxypyrimidine derivatives |
US5077293A (en) * | 1990-06-29 | 1991-12-31 | Bristol-Myers Squibb Co. | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines |
GB9022250D0 (en) * | 1990-10-12 | 1990-11-28 | Glaxo Group Ltd | Medicaments |
GB9103770D0 (en) * | 1991-02-22 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
GB9104890D0 (en) * | 1991-03-08 | 1991-04-24 | Glaxo Group Ltd | Compositions |
CA2084531A1 (en) * | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
GB9209882D0 (en) * | 1992-05-07 | 1992-06-24 | Glaxo Lab Sa | Compositions |
GB9211276D0 (en) * | 1992-05-28 | 1992-07-15 | Glaxo Lab Sa | Pharmaceutical compositions |
GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
ES2055651B1 (es) * | 1992-07-20 | 1995-03-01 | Vita Invest Sa | Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles. |
GB9216009D0 (en) * | 1992-07-28 | 1992-09-09 | Almirall Lab | New indol derivatives |
ES2056025B1 (es) * | 1992-10-08 | 1995-05-01 | Almirall Lab | Nuevos derivados de indol. |
US5382592A (en) * | 1993-09-16 | 1995-01-17 | Bristol-Myers Squibb Company | Antimigraine cyclobutenedione derivatives of tryptamines |
US5468768A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antimigraine derivatives of indolylcycloalkanylamines |
ES2079323B1 (es) * | 1994-06-21 | 1996-10-16 | Vita Invest Sa | Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes. |
US5618816A (en) * | 1995-03-02 | 1997-04-08 | Bristol-Myers Squibb Company | Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines |
FR2731224B1 (fr) * | 1995-03-02 | 1997-05-30 | Pf Medicament | Nouveaux derives bi-tryptaminiques sulfonamides, leur procede de preparation et leur utilisation a titre de medicaments |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US6066092A (en) * | 1997-11-06 | 2000-05-23 | Cady; Roger K. | Preemptive prophylaxis of migraine device and method |
US6416472B1 (en) | 1997-11-06 | 2002-07-09 | Edus Inc. | Method and device for measuring cognitive efficiency |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
GB9926250D0 (en) * | 1999-11-06 | 2000-01-12 | Knoll Ag | Chemical process |
WO2002015899A1 (en) * | 2000-08-23 | 2002-02-28 | Bristol-Myers Squibb Company | Combination therapy for the treatment of migraine |
IL157771A0 (en) * | 2001-03-27 | 2004-03-28 | Galen Chemicals Ltd | Intravaginal drug delivery devices for the administration of an antimicrobial agent |
EP1435945B1 (en) * | 2001-06-05 | 2008-08-13 | Aung-din, Ronald | Topical migraine therapy |
US8329734B2 (en) | 2009-07-27 | 2012-12-11 | Afgin Pharma Llc | Topical therapy for migraine |
EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
AU2003243605A1 (en) * | 2002-06-13 | 2003-12-31 | Dr. Reddy's Laboratories Limited | 3-'2-(dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof |
US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
JP4897221B2 (ja) | 2002-12-20 | 2012-03-14 | チバ ホールディング インコーポレーテッド | アミン類の合成及びその合成のための中間体 |
JP4616009B2 (ja) | 2002-12-26 | 2011-01-19 | ポーゼン インコーポレイテッド | NSAIDsおよびトリプタンを含有する多層剤型 |
US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
WO2004076403A1 (en) * | 2003-02-24 | 2004-09-10 | Transform Pharmaceuticals, Inc. | Sumatriptan crystalline forms, pharmaceutical compositions and methods |
WO2004110492A2 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and nsaids |
CA2529528A1 (en) | 2003-06-20 | 2004-12-29 | Ronald Aung-Din | Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions |
NZ546183A (en) * | 2003-09-26 | 2011-04-29 | Alza Corp | Controlled release formulations exhibiting an ascending rate of release |
JP5563731B2 (ja) * | 2003-09-26 | 2014-07-30 | アルザ・コーポレーシヨン | オピオイドおよび非オピオイド鎮痛薬の制御放出製剤 |
ATE504288T1 (de) * | 2003-09-26 | 2011-04-15 | Alza Corp | Oros-push-stick für die kontrollierte abgabe von wirkstoffen |
JP4919801B2 (ja) * | 2003-09-26 | 2012-04-18 | アルザ・コーポレーシヨン | 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法 |
EP1765300A2 (en) * | 2004-06-10 | 2007-03-28 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
US8541026B2 (en) * | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
CN101247853B (zh) | 2005-04-13 | 2014-11-12 | 轴突公司 | 具有nos抑制活性的取代的吲哚化合物 |
WO2007070504A2 (en) * | 2005-12-13 | 2007-06-21 | Morton Grove Pharmaceuticals, Inc. | Stable and palatable oral liquid sumatriptan compositions |
AR060451A1 (es) * | 2006-04-13 | 2008-06-18 | Neuraxon Inc | Compuestos de indol 1,5 y 3,6-sustituidos con actividad inhibitoria de nos |
US20080103189A1 (en) * | 2006-10-19 | 2008-05-01 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted indoles |
AU2008321353A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
CA2705833A1 (en) * | 2007-11-16 | 2009-05-22 | Subhash C. Annedi | 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
NZ586082A (en) * | 2007-11-16 | 2013-03-28 | Neuraxon Inc | Indole compounds and methods for treating visceral pain |
US20090252791A1 (en) * | 2008-04-02 | 2009-10-08 | Venkata Nookaraju Sreedharala | Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug |
KR20110019759A (ko) | 2008-05-27 | 2011-02-28 | 비오타 사이언티픽 매니지먼트 피티와이 엘티디 | 항바이러스 염 |
CA2765866C (en) * | 2008-06-20 | 2016-06-21 | Alphapharm Pty Ltd | Single phase pharmaceutical composition of a 5-ht1 inhibitor and an nsaid |
US8592424B2 (en) * | 2008-06-30 | 2013-11-26 | Afgin Pharma Llc | Topical regional neuro-affective therapy |
NZ599344A (en) * | 2009-09-25 | 2015-02-27 | Reddy’S Lab Ltd Dr | Formulations comprising triptan compounds |
US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
BR112017018944A2 (pt) | 2015-03-02 | 2018-05-15 | Afgin Pharma Llc | método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s) |
US10383816B2 (en) | 2015-03-02 | 2019-08-20 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoid combination products |
US10537554B2 (en) | 2015-08-05 | 2020-01-21 | Upsher-Smith Laboratories, Llc | Pharmaceutical composition for treating migraine |
US20210069122A1 (en) | 2016-01-27 | 2021-03-11 | Instar Technologies A.S. | Oromucosal nanofiber carriers for therapeutic treatment |
US20180049994A1 (en) | 2016-08-16 | 2018-02-22 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with caryophyllene |
EP3766483A1 (en) | 2019-07-19 | 2021-01-20 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising a triptan |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
ES8300699A1 (es) * | 1980-08-12 | 1982-11-01 | Glaxo Group Ltd | Procedimiento para la preparacion de derivados del indol. |
ZA815540B (en) * | 1980-08-12 | 1983-03-30 | Glaxo Group Ltd | Heterocyclic compounds |
GB2082175B (en) * | 1980-08-12 | 1984-05-02 | Glaxo Group Ltd | Heterocyclic compounds |
ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
-
1983
- 1983-06-03 GR GR71558A patent/GR79215B/el unknown
- 1983-06-03 IT IT48422/83A patent/IT1170387B/it active Protection Beyond IP Right Term
- 1983-06-06 DK DK2601/83A patent/DK260183D0/da not_active Application Discontinuation
- 1983-06-07 JP JP58101587A patent/JPS5942366A/ja active Granted
- 1983-06-07 IL IL68913A patent/IL68913A/xx not_active IP Right Cessation
- 1983-06-07 KR KR1019830002526A patent/KR900006681B1/ko not_active IP Right Cessation
- 1983-06-07 PH PH29020A patent/PH19908A/en unknown
- 1983-06-07 LU LU84852A patent/LU84852A1/fr unknown
- 1983-06-07 GB GB08315564A patent/GB2124210B/en not_active Expired
- 1983-06-07 SE SE8303208A patent/SE452459B/sv not_active IP Right Cessation
- 1983-06-07 BE BE0/210953A patent/BE896986A/fr not_active IP Right Cessation
- 1983-06-07 PT PT76830A patent/PT76830B/pt unknown
- 1983-06-07 AT AT0208483A patent/AT381933B/de not_active IP Right Cessation
- 1983-06-07 NZ NZ204482A patent/NZ204482A/en unknown
- 1983-06-07 NL NL8302031A patent/NL193694C/nl not_active IP Right Cessation
- 1983-06-07 AU AU15441/83A patent/AU566149B2/en not_active Expired
- 1983-06-07 IE IE1335/83A patent/IE55358B1/en not_active IP Right Cessation
- 1983-06-07 FR FR8309429A patent/FR2530625B1/fr not_active Expired
- 1983-06-07 FI FI832035A patent/FI79530C/fi not_active IP Right Cessation
- 1983-06-07 DE DE19833320521 patent/DE3320521A1/de active Granted
- 1983-06-07 CA CA000429902A patent/CA1199643A/en not_active Expired
- 1983-06-07 ES ES523039A patent/ES8407473A1/es not_active Expired
- 1983-06-07 DE DE1993175045 patent/DE19375045I2/de active Active
- 1983-06-07 ZA ZA834110A patent/ZA834110B/xx unknown
- 1983-06-07 CH CH3117/83A patent/CH657359A5/fr not_active IP Right Cessation
-
1984
- 1984-02-16 ES ES529802A patent/ES529802A0/es active Granted
-
1985
- 1985-06-17 ES ES544281A patent/ES8609247A1/es not_active Expired
- 1985-11-15 US US06/789,831 patent/US4816470A/en not_active Expired - Lifetime
-
1987
- 1987-12-30 MY MY179/87A patent/MY8700179A/xx unknown
-
1988
- 1988-09-30 KE KE3833A patent/KE3833A/xx unknown
-
1989
- 1989-02-16 HK HK147/89A patent/HK14789A/xx not_active IP Right Cessation
- 1989-07-21 CY CY1458A patent/CY1458A/xx unknown
- 1989-11-20 DO DO4760001989A patent/DOP1989476000A/es unknown
-
1991
- 1991-12-23 CZ CS914040A patent/CZ280529B6/cs unknown
- 1991-12-23 SK SK4040-91A patent/SK277877B6/sk unknown
-
1992
- 1992-06-02 MX MX9202623A patent/MX9202623A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES523039A0 (es) | "un procedimiento para la preparacion de derivados del indol" | |
ES522447A0 (es) | Procedimiento para la preparacion de 1,4-diceto-pirrollo-3,4-c-pirroles | |
ES546631A0 (es) | Un procedimiento para la preparacion de derivados de indol | |
ES511498A0 (es) | Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol | |
ES526295A0 (es) | Un procedimiento para la preparacion de derivados de 1-normon-2-ilo | |
ES531660A0 (es) | Un procedimiento para la preparacion de nuevos derivados arilfenilicos | |
ES535980A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina | |
ES522886A0 (es) | "procedimiento para la preparacion de derivados de 1-sulfo-2-oxoacetidina" | |
ES531561A0 (es) | Un procedimiento para la preparacion de derivados de azetidina | |
AR241017A1 (es) | "procedimiento para la preparacion de fenilsilfoniloxibencimidazolcarbamatos sustituidos". | |
ES524399A0 (es) | Un procedimiento para la preparacion de derivados de milbenicina d | |
ES544290A0 (es) | Un procedimiento para la preparacion de derivados del indano | |
ES530669A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos | |
ES524154A0 (es) | Procedimiento para la preparacion de n-arilsulfonil-n'-triazolureas | |
ES511834A0 (es) | "procedimiento para la preparacion de nuevas indolinonas". | |
ES508811A0 (es) | "prodedimiento para la preparacion de derivados de fenoxi-aminipropanol" | |
ES508293A0 (es) | "procedimiento para la preparacion de derivados de tiazolina". | |
ES540345A0 (es) | Un procedimiento para la preparacion de derivados de piperi-dina | |
ES530388A0 (es) | Procedimiento para preparar derivados del 2-azabiciclo-2.2.1-heptano. | |
ES527804A0 (es) | Un procedimiento para la preparacion de derivados de oxacefalosporina | |
ES508152A0 (es) | "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina". | |
AR240934A1 (es) | Procedimiento para obtener derivados de acridanona" | |
ES526569A0 (es) | Procedimiento para la preparacion de alcanolaminoxi-derivados de la 3,4-dihidro-2h-1,4-benzotiazin-3-ona | |
ES508723A0 (es) | "un procedimiento para la preparacion de derivados de metoxicefalosporinas". | |
ES522884A0 (es) | "un procedimiento para la preparacion de derivados de hidroxiimino y alcoxiimino de 1,4-dihidropiridina" |